Amino Acids, Peptides, and Proteins: News and Research on Monokines

MeSH tree: D12.776.467.374.500

How a multiple sclerosis drug reshapes the immune system

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that depletes B cells—the immune ...

page 3 from 9